[Federal Register Volume 70, Number 34 (Tuesday, February 22, 2005)]
[Rules and Regulations]
[Pages 8513-8514]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-3280]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 520
Oral Dosage Form New Animal Drugs; Ivermectin Paste
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect approval of an abbreviated new animal drug
application (ANADA) filed by Cross Vetpharm Group Ltd. The ANADA
provides for oral use of ivermectin paste in horses for treatment and
control of various internal parasites or parasitic conditions.
DATES: This rule is effective February 22, 2005.
FOR FURTHER INFORMATION CONTACT: Lonnie W. Luther, Center for
Veterinary
[[Page 8514]]
Medicine (HFV-104), Food and Drug Administration, 7519 Standish Pl.,
Rockville, MD 20855, 301-827-8549, e-mail: [email protected].
SUPPLEMENTARY INFORMATION: Cross Vetpharm Group Ltd., Broomhill Rd.,
Tallaght, Dublin 24, Ireland, filed ANADA 200-326 for BIMECTIN
(ivermectin) Paste 1.87%. The application provides for oral use of 1.87
percent ivermectin paste in horses for the treatment and control of
various species of internal parasites or parasitic conditions. Cross
Vetpharm Group's BIMECTIN Paste 1.87% is approved as a generic copy of
Merial Limited's EQVALAN Paste, approved under NADA 134-314. ANADA 200-
326 is approved as of January 19, 2005, and 21 CFR 520.1192 is amended
to reflect the approval. The basis of approval is discussed in the
freedom of information summary.
In accordance with the freedom of information provisions of 21 CFR
part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and
effectiveness data and information submitted to support approval of
this application may be seen in the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
The agency has determined under 21 CFR 25.33(a)(1) that this action
is of a type that does not individually or cumulatively have a
significant effect on the human environment. Therefore, neither an
environmental assessment nor an environmental impact statement is
required.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 520
Animal drugs.
0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is
amended as follows:
PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS
0
1. The authority citation for 21 CFR part 520 continues to read as
follows:
Authority: 21 U.S.C. 360b.
0
2. Section 520.1192 is amended by adding paragraphs (b)(3) and
(e)(1)(ii)(C) to read as follows:
Sec. 520.1192 Ivermectin paste.
* * * * *
(b) * * *
(3) No. 061623 for use of a 1.87 percent paste for use as in
paragraph (e)(1)(i), (e)(1)(ii)(C), and (e)(1)(iii) of this section.
* * * * *
(e) * * *
(1) * * *
(ii) * * *
* * * * *
(C) Large strongyles (adults)--Strongylus vulgaris (also early
forms in blood vessels), S. edentatus (also tissue stages), S. equinus,
and Triodontophorus spp. including T. brevicauda and T. serratus; Small
Strongyles (adults, including those resistant to some benzimidazole
class compounds)--Cyathostomum spp. including C. catinatum and C.
pateratum, Cylicocyclus spp. including C. insigne, C. leptostomum, C.
nassatus, and C. brevicapsulatus, Cylicodontophorus spp., and
Cylicostephanus spp. including C. calicatus, C. goldi, C.
longibursatus, and C. minutus; Small Strongyles--fourth-stage larvae;
Pinworms (adults and fourth-stage larvae)--Oxyuris equi; Ascarids
(adults and third- and fourth-stage larvae)--Parascaris equorum;
Hairworms (adults)--Trichostrongylus axei; Large-mouth Stomach Worms
(adults)--Habronema muscae; Bots (oral and gastric stages)--
Gasterophilus spp. including G. intestinalis and G. nasalis; Lungworms
(adults and fourth-stage larvae)--Dictyocaulus arnfieldi; Intestinal
Threadworms (adults)--Strongyloides westeri; Summer Sores caused by
Habronema and Draschia spp. cutaneous third-stage larvae; Dermatitis
caused by neck threadworm microfilariae, Onchocerca sp.
* * * * *
Dated: February 8, 2005.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 05-3280 Filed 2-18-05; 8:45 am]
BILLING CODE 4160-01-S